Trial Profile
The Role of Regional Anesthesia to Reduce Opioid Requirements Following Functional Endoscopic Sinus Surgery (FESS)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Sep 2022
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary) ; Dexamethasone (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 04 Feb 2022 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.
- 27 Sep 2021 Planned End Date changed from 1 Aug 2022 to 1 Dec 2022.
- 27 Sep 2021 Planned primary completion date changed from 1 Aug 2021 to 1 Dec 2021.